Compare Injective (INJ) vs Neutron (NTRN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Neutron — how do they compare? Injective trades at Rp92,698 (market cap Rp9,29T, Rp1,78T 24h volume), while Neutron trades at Rp25.52 (market cap Rp78,1M, Rp76,5M 24h volume). The key difference: Injective is far larger — about 118950.1× Neutron's market cap, and Neutron's supply is capped (804,1M / 999,7M NTRN (81%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Neutron for 37 Days on average.
| INJ | NTRN | |
|---|---|---|
Market Cap | Rp9,29T | Rp78,1M |
Volume (24h) | Rp1,78T | Rp76,5M |
Circulating Supply | 100M INJ | 804,1M / 999,7M NTRN (81%) |
Typical Hold Time | 36 Days | 37 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Neutron (NTRN) holds a market cap of Rp78.1M with 81% of its max supply in circulation. Current price data is unavailable, but the token shows a hold time of 37 days, indicating moderate holding behavior. No recent protocol upgrades or ecosystem developments were identified, suggesting a period of stability without significant network changes.
The outlook remains neutral due to limited data; key opportunities include potential ecosystem growth, while risks involve low liquidity and market volatility. Investors should monitor for new exchange listings and on-chain activity to gauge future momentum.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Neutron
Neutron is the most secure cross-chain smart-contracting platform. It combines the security of a top 10 blockchain by staked capitalization with bleeding-edge cross-chain infrastructure to enable DeFi applications to securely scale across a growing network of 51+ interconnected blockchains.
Read more on NTRN →
